Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
7 offices
Technology Company

We have observed 95 EP applications Elena Böhles has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12811874

METHOD FOR PURIFYING FC-FUSION PROTEIN

IPC classification:
C07K 16/00, C07K 1/22, C07K 1/18
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12811245

METHOD FOR DETECTION OF AMYLOID BETA OLIGOMERS IN A FLUID SAMPLE AND USES THEREOF

IPC classification:
G01N 33/53, G01N 21/76
Applicant:
Merck & Co. Inc.
Agent:
Maura O'Connell, F. R. Kelly & Co.
Agent:
Elena Böhles, Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12825540

CRYSTAL FORMS OF A HCV PROTEASE INHIBITOR

IPC classification:
A61K 38/12
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825726

METHODS AND INTERMEDIATES FOR PREPARING MACROLACTAMS

IPC classification:
A61K 31/70, A61K 31/44, A01N 43/42, A01N 43/04
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12821921

N-GLYCOSYLATED INSULIN ANALOGUES

IPC classification:
A61K 38/28, C07K 14/62
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12834491

CELL SURFACE DISPLAY OF LIGANDS FOR THE INSULIN AND/OR INSULIN GROWTH FACTOR 1 RECEPTOR AND APPLICATIONS THEREOF

IPC classification:
G01N 33/569, G01N 33/567, C40B 40/02
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12843508

ENGINEERED LOWER EUKARYOTIC HOST STRAINS FOR RECOMBINANT PROTEIN EXPRESSION

IPC classification:
C12N 15/09, C07H 21/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12843872

CONTROLLING O-GLYCOSYLATION IN LOWER EUKARYOTES

IPC classification:
C12P 21/06, C12N 15/00, C12N 1/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12844827

BIOMARKERS FOR TSLP TREATMENT

IPC classification:
G01N 33/53, C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12846590

METHODS OF PREPARING LYOPHILIZED SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12846186

CHROMATOGRAPHY PROCESS FOR RESOLVING HETEROGENEOUS ANTIBODY AGGREGATES

IPC classification:
C12P 21/08, C07K 16/00, B01D 15/08
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12845161

METHOD FOR PREPARING ANTIBODIES HAVING IMPROVED PROPERTIES

IPC classification:
A61K 39/395, C07K 16/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12846655

PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS SA2074 PROTEIN

IPC classification:
C07K 14/31
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12811568

IL-23 ANTAGONISTS FOR TREATMENT OR PREVENTION OF SKIN RASH ASSOCIATED WITH TREATMENT WITH P13K/AKT PATHWAY INHIBITORS

IPC classification:
A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12849080

Fc CONTAINING POLYPEPTIDES HAVING INCREASED ANTI-INFLAMMATORY PROPERTIES AND INCREASED FcRN BINDING

IPC classification:
C12P 21/08
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12846671

ENGINEERED PICHIA STRAINS WITH IMPROVED FERMENTATION YIELD AND N-GLYCOSYLATION QUALITY

IPC classification:
C12P 21/00, C12N 15/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859353

PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS

IPC classification:
A61K 39/104, C07K 16/12, C07K 14/21
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13740509

VACCINES AGAINST CLOSTRIDIUM DIFFICILE COMPRISING RECOMBINANT TOXINS

IPC classification:
C07K 14/33
Applicant:
Merck & Co. Inc.
Applicant:
MSD Animal Health
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13749326

METHODS FOR REDUCING MANNOSYLTRANSFERASE ACTIVITY IN YEAST

IPC classification:
C12N 1/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12826404

PROCESS AND INTERMEDIATES FOR PREPARING MACROLACTAMS

IPC classification:
A61K 31/70, A61K 31/44, A01N 43/42, A01N 43/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP12810612

5'-SUBSTITUTED NUCLEOSIDE ANALOGS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/415, C07H 19/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12811164

5'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/415, C07H 19/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12802183

HPV VACCINE FORMULATIONS COMPRISING ALUMINUM ADJUVANT AND METHODS OF PRODUCING SAME

IPC classification:
A61K 47/26, A61K 47/18, A61K 47/02, A61K 39/12, A61K 39/00, A61K 9/19, A61K 9/00, C12N 15/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13763727

STABLE PEPTIDE MIMETICS OF THE HIV-1 GP41 PRE-HAIRPIN INTERMEDIATE

IPC classification:
A61K 39/21, A61K 38/00, G01N 33/53, C12N 7/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13769724

1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/439, C07D 471/08, A61P 31/04
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Carpmaels & Ransford LLP
Status:
The patent has been granted
EP13769389

ISOXAZOLE beta-LACTAMASE INHIBITORS

IPC classification:
A61K 31/46, C07D 451/06, A61P 31/00
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12823625

USE OF INORGANIC MATRIX AND ORGANIC POLYMER COMBINATIONS FOR PREPARING STABLE AMORPHOUS DISPERSIONS

IPC classification:
A61K 47/38, A61K 47/02, A61K 31/496, A61K 31/444, A61K 31/437, A61K 31/405, A61K 31/277, A61K 9/14, A61K 9/10
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13778279

BIOMARKERS FOR MONITORING INTERVENTION THERAPIES FOR DIABETES

IPC classification:
A61K 31/70
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13787435

SURFACE ANCHORED LIGHT CHAIN BAIT ANTIBODY DISPLAY SYSTEM

IPC classification:
C40B 30/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13770320

IGF1 BIOMARKER FOR IGF1R INHIBITOR THERAPY

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13748245

HCV NS3 PROTEASE INHIBITORS

IPC classification:
A61K 31/407, A61K 31/343, C07D 491/107, A61P 31/14, A61P 1/16
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13854963

LIQUID FORMULATIONS FOR TNFR:FC FUSION PROTEINS

IPC classification:
A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13861070

O-GLYCOSYLATED CARBOXY TERMINAL PORTION (CTP) PEPTIDE-BASED INSULIN AND INSULIN ANALOGUES

IPC classification:
A61K 38/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13858630

IMPROVED CULTIVATION MEDIA AND PROCESS FOR IMPROVED PROTEIN PRODUCTION BY PICHIA STRAINS

IPC classification:
C12P 21/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13863050

ENGINEERED LOWER EUKARYOTIC HOST STRAINS DEFICIENT IN GRR1 ACTIVITY FOR RECOMBINANT PROTEIN EXPRESSION

IPC classification:
C12N 1/19
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13862934

MEDICATION INJECTOR WITH NEAR-EMPTY ALERT

IPC classification:
A61M 5/315
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13861823

LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES

IPC classification:
A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Michelle O'Neill, Harrison IP Limited
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13864587

PROCESS FOR PURIFYING INSULIN AND ANALOGUES THEREOF

IPC classification:
A61K 38/28, C07K 14/62
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13863785

PMT2, OCH1, PMT5 MUTANT CELLS

IPC classification:
C12N 15/63, C12N 15/52
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13864159

BIOMARKERS FOR PSORIASIS TREATMENT RESPONSE

IPC classification:
C12Q 1/68, A61P 17/06
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP15166643

ILT3 BINDING MOLECULES AND USES THEREFOR

IPC classification:
A61K 39/395, A61K 39/00, C07K 16/28, C07K 14/705
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13865458

LIQUID FORMULATIONS FOR AN ANTI-TNF ALPHA ANTIBODY

IPC classification:
A61K 39/395, A61K 39/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13865827

DUAL CHAMBER MIXING SYRINGES AND METHODS OF USING SAME

IPC classification:
A61M 5/32
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13814812

ANTIBODIES THAT BIND TO HUMAN PROGRAMMED DEATH LIGAND 1 (PD-L1)

IPC classification:
G01N 33/577, G01N 33/574, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13863926

ON-COLUMN REFOLDING AND PURIFYING OF LIPOPROTEINS

IPC classification:
C07K 14/775
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14749562

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/44, A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14748737

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/397, A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14752178

METHODS FOR INCREASING N-GLYCAN OCCUPANCY AND REDUCING PRODUCTION OF HYBRID N-GLYCANS IN PICHIA PASTORIS STRAINS LACKING ALG3 EXPRESSION

IPC classification:
C07K 9/00, A61K 38/16
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14775102

ADAPTED LEPIDOPTERAN INSECT CELLS FOR THE PRODUCTION OF RECOMBINANT PROTEINS

IPC classification:
C12N 5/10
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14778739

IMMUNOHISTOCHEMICAL ASSAY FOR DETECTING EXPRESSION OF PROGRAMMED DEATH LIGAND 1 (PD-L1) IN TUMOR TISSUE

IPC classification:
G01N 33/53
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14810345

PREPARATION OF TERT-BUTYL 4-((1R,2S,5R)-6- (BENZYLOXY)-7-0X0-1,6-DIAZABICYCL0[3.2.I]OCTANE-2- CARBOXAMIDO)PIPERIDINE-1-CARBOXYLATE

IPC classification:
C07D 211/00, C07D 491/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14814205

DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 39/193, A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP15196341

ANTI-GITR ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14836140

METHODS AND COMPOSITIONS FOR CO-EXPRESSION OF POLYPEPTIDES OF INTEREST AND IL6

IPC classification:
C12N 5/02, C12N 15/00, C12N 15/87, C12N 5/07
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14837218

TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB

IPC classification:
A01N 43/90, C07K 14/475, C07K 16/00, A61K 39/395
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14761460

MODULATION OF TUMOR IMMUNITY

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14854498

THERMOSTABLE RESPIRATORY SYNCTIAL VIRUS (RSV) VACCINE COMPOSITIONS

IPC classification:
A61P 31/14, A61K 9/19, A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854464

METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

IPC classification:
C07K 1/36
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854507

METHOD OF OBTAINING THERMOSTABLE DRIED VACCINE FORMULATIONS

IPC classification:
A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14870360

IMMUNOHISTOCHEMICAL PROXIMITY ASSAY FOR PD-1 POSITIVE CELLS AND PD-LIGAND POSITIVE CELLS IN TUMOR TISSUE

IPC classification:
A61P 35/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872286

IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15740828

METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
C07D 257/04, A61K 31/4184, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15761797

PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE

IPC classification:
C07K 1/00, A61K 38/00, A61K 38/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15773458

PHOSPHATE BASED LINKERS FOR INTRACELLULAR DELIVERY OF DRUG CONJUGATES

IPC classification:
A61K 47/24
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15789928

BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/192, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15824392

CHROMATOGRAPHY PROCESS FOR PURIFICATION OF INLSULIN AND INSULIN ANALOGS

IPC classification:
C07K 14/62, A61K 38/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15827553

MONOCYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN

IPC classification:
C07D 261/00, A61P 9/00, A61K 31/42
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15827441

ANTI-CTLA4 MONOCLONAL ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, MEDICINAL COMPOSITION AND USE

IPC classification:
C07K 19/00, C12N 15/63, C12N 5/10, C12N 1/21, G01N 33/577, A61P 37/04, A61P 35/00, A61K 39/395, C12N 15/13, C07K 16/28
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15830117

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
A61K 31/357
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15829663

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
C07D 311/20, A61K 31/353, A61K 31/192
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15829695

[7,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS

IPC classification:
A61K 31/34, A61K 31/343, A61K 31/47, A61K 31/44, A61K 31/192, C07D 307/80, C07D 413/00, C07D 215/20, C07D 215/16, C07D 493/04, C07D 409/12
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15753872

ANTI-TIGIT ANTIBODIES

IPC classification:
A61K 39/00, A61P 37/02, A61K 39/395, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15753877

ANTI-LAG3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

IPC classification:
C07K 16/28, A61P 37/02, A61K 39/00, A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15753363

METHODS OF TREATING LYMPHOMA USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61P 35/00, A61K 31/5517
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15836281

METHOD FOR PREPARING CRYSTALLINE INSULIN OR INSULIN ANALOG COMPOSITIONS

IPC classification:
C07K 14/62, C07K 1/32, A61K 47/02, A61K 38/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15790398

CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

IPC classification:
A61K 38/28, A61K 38/26, C07K 14/605
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15860890

PROCESS FOR PRODUCING RECOMBINANT TRYPSIN

IPC classification:
A61K 38/48, C12R 1/19, C12N 9/76
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15862029

PROCESS FOR REFOLDING RECOMBINANT CHYMOTRYPSIN

IPC classification:
A61K 38/48, C12R 1/19, C12N 9/76
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15801104

TRIAZOLO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61P 9/00, A61K 31/519, C07D 487/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15866163

NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15866280

NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15865691

NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15868101

SYSTEM AND METHODS FOR DERIVING GENE SIGNATURE BIOMARKERS OF RESPONSE TO PD-1 ANTAGONISTS

IPC classification:
A61K 39/395, A61K 39/00, C40B 30/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP17171651

A CONDITIONAL REPLICATING CYTOMEGALOVIRUS AS A VACCINE FOR CMV

IPC classification:
C07H 21/04, A61K 48/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
The application has been published
EP16756100

CRYSTALS OF ANTI-HUMAN PD-1 MONOCLONAL ANTIBODIES

IPC classification:
A61K 39/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16762165

PROCESS FOR PREPARING RECOMBINANT INSULIN USING MICROFILTRATION

IPC classification:
C12P 21/06, C12P 21/00, C12N 15/09, C12N 9/50, C07K 14/62
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16777098

GLUCOSE-RESPONSIVE INSULIN CONJUGATES

IPC classification:
A61K 38/28, A61K 47/48
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16780526

BLOOD-BASED BIOMARKERS OF TUMOR SENSITIVITY TO PD-1 ANTAGONISTS

IPC classification:
G01N 33/68, G01N 33/574, G01N 33/566, G01N 33/543
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16793299

IN VITRO

IPC classification:
G01N 33/50, G01N 33/48, C12M 3/06, C12M 3/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16800577

IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16800578

IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16734151

3-TETRAZOLYL-BENZENE-1,2-DISULFONAMIDE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
A61P 31/04, A61K 31/4439, A61K 31/428, A61K 31/4184, A61K 31/41, C07D 471/04, C07D 417/14, C07D 417/10, C07D 413/10, C07D 407/14, C07D 403/14, C07D 403/10, C07D 401/10, C07D 413/14, C07D 403/12
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16815358

METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/395, A61K 31/41, C07D 257/04, C07D 257/02
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16729940

BACKSTOP FOR A SYRINGE

IPC classification:
A61M 5/315, A61M 5/178
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16824927

BICYCLIC HETEROCYCLES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN

IPC classification:
C07D 498/04, A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made

Please Sign in to use this feature